Varicella Vaccination With Pulmicort

A study to determine whether treatment with Pulmicort in children has any effect on the varicella vaccine

Completed

Looking for future studies?

Key information

Conditions

Asthma Bronchial Diseases Chickenpox DNA Virus Infections Herpesviridae Infections Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Infections Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases Varicella Zoster Virus Infection Virus Diseases

Age range

10 month–8 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children between the age of 10 months and 8 years,
have asthma or shown recent signs suggesting asthma,
have a parent or guardian willing to comply with study requirements

Exclusion criteria

Varicella zoster immune globulin (VZIG) within 5 months prior to immunization,
Previous varicella immunization,
an immunization or allergy immunotherapy 4 weeks prior to immunization,
Severe asthma,
have another persistent lung disease,
have a planned hospitalization for the duration of study

Treatment and study plan

Budesonide

Drug

Other names: Pulmicort

varicella zoster virus

Drug

Other names: Varivax

Primary outcomes

Seroconversion level

Time frame: Week 6

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

Rates of Seroconversion Following Varicella Vaccination of Asthmatic Children Between the Ages of One and Eight Years Treated With Pulmicort Respules® Versus Non-Steroidal Conventional Asthma Therapy

Important dates

Study start: 2001
Primary completion: 2003
Study completion: 2003
First posted: Mar 24, 2008
Registry last updated: Mar 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed